Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura A. Rudolph-Owen is active.

Publication


Featured researches published by Laura A. Rudolph-Owen.


Journal of Biopharmaceutical Statistics | 2004

Detection of Activity Centers in Cellular Pathways Using Transcript Profiling

Joël R. Pradines; Laura A. Rudolph-Owen; John Joseph Hunter; Patrick J. LeRoy; Michael P. Cary; Robert Coopersmith; Vlado Dancik; Yelena Eltsefon; Victor Farutin; Christophe Leroy; Jonathan Rees; David Rose; Steve Rowley; Alan Ruttenberg; Patrick Wieghardt; Chris Sander; Christian Reich

Abstract We present a new computational method for identifying regulated pathway components in transcript profiling (TP) experiments by evaluating transcriptional activity in the context of known biological pathways. We construct a graph representing thousands of protein functional relationships by integrating knowledge from public databases and review articles. We use the notion of distance in a graph to define pathway neighborhoods. The pathways perturbed in an experiment are then identified as the subgraph induced by the genes, referred to as activity centers, having significant density of transcriptional activity in their functional neighborhoods. We illustrate the predictive power of this approach by performing and analyzing an experiment of TP53 overexpression in NCI-H125 cells. The detected activity centers are in agreement with the known TP53 activation effects and our independent experimental results. We also apply the method to a serum starvation experiment using HEY cells and investigate the predicted activity of the transcription factor MYC. Finally, we discuss interesting properties of the activity center approach and its possible applications beyond the comparison of two experiments.


American Journal of Physiology-gastrointestinal and Liver Physiology | 2002

Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus

Sanjay K. Mistry; Tim Burwell; Rebecca M. Chambers; Laura A. Rudolph-Owen; Frank Spaltmann; W. Jim Cook; Sidney M. Morris


Archive | 2001

32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor

Rachel E. Meyers; William James Cook; Mark Williamson; Laura A. Rudolph-Owen


Archive | 2003

27411, a novel human PGP synthase

Maria Alexandra Glucksmann; Mark J. Williamson; Fong-Ying Tsai; Laura A. Rudolph-Owen; Rosanna Kapeller-Libermann; Rachel E. Meyers; Lillian Wei-Ming Chiang; John Joseph Hunter


Archive | 2006

Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor

Rosana Kapeller-Libermann; John Joseph Hunter; Rachel E. Meyers; Laura A. Rudolph-Owen; Rory A. J. Curtis; Peter J. Olandt; Fong-Ying Tsai; Katherine M. Galvin; Miyoung Chun; Mark J. Williamson; Inmaculada Silos-Santiago; Rajasekhar Bandaru


Archive | 2005

Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor

Rajasekhar Bandaru; Maria Alexandra Glucksmann; Rachel E. Meyers; Laura A. Rudolph-Owen


Archive | 2003

Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules

John Joseph Hunter; Kyle J. Macbeth; Fong-Ying Tsai; Andrea Lesoon; Mark J. Williamson; Laura A. Rudolph-Owen


Archive | 2001

22438, 23553, 25278, and 26212 novel human sulfatases

Maria Alexandra Glucksmann; Mark Williamson; Fong Ying Tsai; Laura A. Rudolph-Owen


Archive | 2001

Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941

Katherine A. Galvin; Laura A. Rudolph-Owen


Archive | 2008

Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor

Rory A. J. Curtis; Thomas Joseph Logan; Maria Alexandra Glucksmann; Rachel E. Meyers; Mark J. Williamson; Laura A. Rudolph-Owen; Miyoung Chun; Fong-Ying Tsai

Collaboration


Dive into the Laura A. Rudolph-Owen's collaboration.

Top Co-Authors

Avatar

Rachel E. Meyers

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Fong-Ying Tsai

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kyle J. Macbeth

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Williamson

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Rory A. J. Curtis

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rachel A. Meyers

Millennium Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge